Mark A Goldsmith
Director, President and Chief Executive Officer · 5 filings · Latest: Jun 16, 2026
Revolution Medicines, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RVMD | MARK A GOLDSMITH | — | Oct 17, 2025 | Proposed Sale | $49.68 | 10,000 | $496.8K | — | |
RVMD | MARK A GOLDSMITH | — | Oct 16, 2025 | Proposed Sale | $49.56 | 10,000 | $495.6K | — | |
RVMD | GOLDSMITH MARK A | — | Sep 15, 2025 | Proposed Sale | $46.55 | 13,236 | $616.1K | — | |
RVMD | GOLDSMITH MARK A | — | Jun 16, 2025 | Proposed Sale | $40.79 | 13,235 | $539.9K | — | |
RVMD | GOLDSMITH MARK A | — | Mar 17, 2025 | Proposed Sale | $38.89 | 11,890 | $462.4K | — | |
RVMD | GOLDSMITH MARK A | — | Dec 16, 2024 | Proposed Sale | $44.93 | 11,561 | $519.4K | — | |
RVMD | REBECCA EVE GOLDSMITH TR U/A DTD 12/15/2011 | — | Nov 1, 2024 | Proposed Sale | $53.50 | 5,000 | $267.5K | — | |
RVMD | J H GOLDSMITH & M A GOLDSMITH CO-TTEE JONATHAN GOLDSMITH REV TRU/A/D 8/16/2023 | — | Nov 1, 2024 | Proposed Sale | $53.50 | 5,000 | $267.5K | — | |
RVMD | MARK A GOLDSMITH | — | Nov 1, 2024 | Proposed Sale | $53.50 | 60,000 | $3.2M | — | |
RVMD | MARK A GOLDSMITH | — | Oct 11, 2024 | Proposed Sale | $49.50 | 30,000 | $1.5M | — | |
RVMD | MARK A GOLDSMITH | — | Oct 1, 2024 | Proposed Sale | $45.35 | 10,000 | $453.5K | — | |
RVMD | GOLDSMITH MARK A | — | Sep 16, 2024 | Proposed Sale | $42.12 | 11,561 | $486.9K | — |
← Previous
Page 2 of 2